应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SPRO Spero Therapeutics Inc.
盘后交易 04-25 17:27:30 EDT
1.43
+0.01
+0.70%
盘后
1.41
-0.02
-1.29%
17:18 EDT
最高
1.46
最低
1.39
成交量
17.55万
今开
1.42
昨收
1.42
日振幅
5.07%
总市值
7,707万
流通市值
5,694万
总股本
5,389万
成交额
25.04万
换手率
0.44%
流通股本
3,982万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Spero Therapeutics, Inc.盘中异动 下午盘大幅跳水5.00%报1.56美元
自选股智能写手 · 04-16
Spero Therapeutics, Inc.盘中异动 下午盘大幅跳水5.00%报1.56美元
Spero Therapeutics, Inc.盘中异动 快速下挫5.25%
自选股智能写手 · 04-12
Spero Therapeutics, Inc.盘中异动 快速下挫5.25%
Spero Therapeutics, Inc.2023财年实现净利润22.81百万美元,同比增加149.14%
自选股智能写手 · 03-14
Spero Therapeutics, Inc.2023财年实现净利润22.81百万美元,同比增加149.14%
Spero Therapeutics Inc盘中异动 下午盘快速拉升7.69%
自选股智能写手 · 2023-12-20
Spero Therapeutics Inc盘中异动 下午盘快速拉升7.69%
加载更多
公司概况
公司名称:
Spero Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Spero Therapeutics, Inc.,前称为Spero Therapeutics,LLC,于2013年12月根据特拉华州的法律成立。该公司是一个多资产,临床阶段的生物制药公司,专注于识别、开发和营销治疗MDR细菌感染的新疗法。该公司还拥有一项名为“潜力平台”的平台技术,他们相信这将使他们开发出能够扩大现有抗生素的范围和效力的药物,包括以前不活跃的抗生素,对抗革兰氏阴性细菌。他们相信,如果成功地开发和批准了他们的新产品,将会对社区和医院环境中治疗MDR感染的患者产生有意义的影响和重要的商业应用。
发行价格:
--
{"stockData":{"symbol":"SPRO","market":"US","secType":"STK","nameCN":"Spero Therapeutics Inc.","latestPrice":1.43,"timestamp":1714075200000,"preClose":1.42,"halted":0,"volume":175454,"hourTrading":{"tag":"盘后","latestPrice":1.4115,"preClose":1.43,"latestTime":"17:18 EDT","volume":7691,"amount":10858.491434900001,"timestamp":1714079920567},"delay":0,"floatShares":39816653,"shares":53892889,"eps":0.43,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.01,"latestTime":"04-25 17:27:30 EDT","open":1.42,"high":1.46,"low":1.388,"amount":250415.59859439998,"amplitude":0.050704,"askPrice":1.49,"askSize":100,"bidPrice":1.41,"bidSize":1901,"shortable":3,"etf":0,"ttmEps":0.43,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714089600000},"adr":0,"listingDate":1509595200000,"adjPreClose":1.42,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.42,"preClose":1.42,"latestTime":"09:19 EDT","volume":5,"amount":7.1,"timestamp":1714051155781},"postHourTrading":{"tag":"盘后","latestPrice":1.4115,"preClose":1.43,"latestTime":"17:18 EDT","volume":7691,"amount":10858.491434900001,"timestamp":1714079920567},"volumeRatio":0.763983},"requestUrl":"/m/hq/s/SPRO/","defaultTab":"news","newsList":[{"id":"2427880035","title":"Spero Therapeutics, Inc.盘中异动 下午盘大幅跳水5.00%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427880035","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427880035?lang=zh_cn&edition=full","pubTime":"2024-04-16 02:51","pubTimestamp":1713207100,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日02时51分,Spero Therapeutics, Inc.股票出现异动,股价快速跳水5.00%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.50%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、安皮奥制药、Longeveron Inc.涨幅较大,Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为1561.82%、1239.78%、875.53%,振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024,振幅分别为273.33%、117.12%、80.04%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416025141861e5e12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416025141861e5e12&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426738828","title":"Spero Therapeutics, Inc.盘中异动 快速下挫5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426738828","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426738828?lang=zh_cn&edition=full","pubTime":"2024-04-12 21:34","pubTimestamp":1712928852,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日21时34分,Spero Therapeutics, Inc.股票出现波动,股价大幅下跌5.25%。Spero Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.33%。其相关个股中,Paxmedica, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Allarity Therapeutics, Inc.涨幅较大,Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃,换手率分别为929.65%、591.04%、27.60%,振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、Veru Inc.,振幅分别为60.75%、12.63%、12.29%。Spero Therapeutics, Inc.公司简介:Spero Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041221341287e7ff20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041221341287e7ff20&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419869219","title":"Spero Therapeutics, Inc.2023财年实现净利润22.81百万美元,同比增加149.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419869219","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419869219?lang=zh_cn&edition=full","pubTime":"2024-03-14 23:23","pubTimestamp":1710429789,"startTime":"0","endTime":"0","summary":"12月31日,Spero Therapeutics, Inc.公布财报,公告显示公司2023财年净利润为22.81百万美元,同比增加149.14%;其中营业收入为96.74百万美元,同比增加99.14%,每股基本收益为0.43美元。机构评级:截至2023年12月31日,当前有2家机构对Spero Therapeutics, Inc.目标价做出预测,其中目标均价为7.50美元,其中最低目标价为7.00美元,最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142323198b3348a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142323198b3348a9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2392634189","title":"Spero Therapeutics Inc盘中异动 下午盘快速拉升7.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2392634189","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2392634189?lang=zh_cn&edition=full","pubTime":"2023-12-20 03:41","pubTimestamp":1703014904,"startTime":"0","endTime":"0","summary":"北京时间2023年12月20日03时41分,Spero Therapeutics Inc股票出现波动,股价大幅拉升7.69%。Spero Therapeutics Inc股票所在的生物技术行业中,整体涨幅为0.04%。其相关个股中,Compugen医疗、Celularity Inc C/Wts 16/07/2026 、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大,Panbela Therapeutics Inc、Compugen医疗、Zyversa Therapeutics Inc较为活跃,换手率分别为1583.92%、115.56%、67.07%,振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Compugen医疗、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为201.92%、116.44%、62.46%。Spero Therapeutics Inc公司简介:Spero Therapeutics Inc是一家总部位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231220034144806b3df9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231220034144806b3df9&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sperotherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0533},{"period":"1month","weight":-0.1598},{"period":"3month","weight":-0.0897},{"period":"6month","weight":0.3922},{"period":"1year","weight":-0.1598},{"period":"ytd","weight":-0.034}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":-0.0276},{"period":"3month","weight":0.0356},{"period":"6month","weight":0.2307},{"period":"1year","weight":0.2446},{"period":"ytd","weight":0.0633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spero Therapeutics, Inc.,前称为Spero Therapeutics,LLC,于2013年12月根据特拉华州的法律成立。该公司是一个多资产,临床阶段的生物制药公司,专注于识别、开发和营销治疗MDR细菌感染的新疗法。该公司还拥有一项名为“潜力平台”的平台技术,他们相信这将使他们开发出能够扩大现有抗生素的范围和效力的药物,包括以前不活跃的抗生素,对抗革兰氏阴性细菌。他们相信,如果成功地开发和批准了他们的新产品,将会对社区和医院环境中治疗MDR感染的患者产生有意义的影响和重要的商业应用。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.068144},{"month":2,"riseRate":0.571429,"avgChangeRate":-0.038645},{"month":3,"riseRate":0.428571,"avgChangeRate":0.002566},{"month":4,"riseRate":0.285714,"avgChangeRate":-0.028483},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.14728},{"month":6,"riseRate":0.5,"avgChangeRate":-0.005052},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.06324},{"month":8,"riseRate":0.333333,"avgChangeRate":0.057076},{"month":9,"riseRate":0.5,"avgChangeRate":0.20913},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.033481},{"month":11,"riseRate":0.666667,"avgChangeRate":0.038495},{"month":12,"riseRate":0.428571,"avgChangeRate":0.001993}],"exchange":"NASDAQ","name":"Spero Therapeutics Inc.","nameEN":"Spero Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spero Therapeutics Inc.(SPRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Spero Therapeutics Inc.(SPRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Spero Therapeutics Inc.,SPRO,Spero Therapeutics Inc.股票,Spero Therapeutics Inc.股票老虎,Spero Therapeutics Inc.股票老虎国际,Spero Therapeutics Inc.行情,Spero Therapeutics Inc.股票行情,Spero Therapeutics Inc.股价,Spero Therapeutics Inc.股市,Spero Therapeutics Inc.股票价格,Spero Therapeutics Inc.股票交易,Spero Therapeutics Inc.股票购买,Spero Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spero Therapeutics Inc.(SPRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Spero Therapeutics Inc.(SPRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}